Bjørnar Gilje

1.7k total citations
52 papers, 968 citations indexed

About

Bjørnar Gilje is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bjørnar Gilje has authored 52 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 26 papers in Cancer Research and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bjørnar Gilje's work include Cancer Genomics and Diagnostics (17 papers), Cancer Cells and Metastasis (15 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Bjørnar Gilje is often cited by papers focused on Cancer Genomics and Diagnostics (17 papers), Cancer Cells and Metastasis (15 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Bjørnar Gilje collaborates with scholars based in Norway, United States and Denmark. Bjørnar Gilje's co-authors include Oddmund Nordgård, Kjersti Tjensvoll, Satu Oltedal, Rune Smaaland, Morten Lapin, Reino Heikkilä, Hartwig Kørner, Jon Arne Søreide, Jan Terje Kvaløy and Milind Javle and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Bjørnar Gilje

51 papers receiving 954 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bjørnar Gilje Norway	19	578	532	302	245	125	52	968
Tamer M. Fouad United States	19	683 1.2×	425 0.8×	211 0.7×	291 1.2×	106 0.8×	41	1.1k
Mads Holten-Andersen Denmark	17	660 1.1×	565 1.1×	246 0.8×	109 0.4×	111 0.9×	37	1.1k
Marzena Wełnicka-Jaśkiewicz Poland	17	610 1.1×	354 0.7×	165 0.5×	154 0.6×	85 0.7×	42	820
J.M.G.H. van Riel Netherlands	14	720 1.2×	382 0.7×	199 0.7×	415 1.7×	67 0.5×	25	989
Nuria Romero-Laorden Spain	14	491 0.8×	223 0.4×	163 0.5×	275 1.1×	123 1.0×	60	779
Idoroenyi Amanam United States	8	529 0.9×	264 0.5×	200 0.7×	215 0.9×	208 1.7×	31	795
Florence Coussy France	15	393 0.7×	295 0.6×	185 0.6×	139 0.6×	99 0.8×	59	734
Shannon McDonough United States	15	989 1.7×	302 0.6×	315 1.0×	262 1.1×	246 2.0×	35	1.2k
Luiz H. Araujo Brazil	13	845 1.5×	391 0.7×	446 1.5×	597 2.4×	107 0.9×	69	1.4k
Luciano de Souza Viana Brazil	18	492 0.9×	223 0.4×	342 1.1×	396 1.6×	50 0.4×	37	968

Countries citing papers authored by Bjørnar Gilje

Since Specialization

Citations

This map shows the geographic impact of Bjørnar Gilje's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bjørnar Gilje with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bjørnar Gilje more than expected).

Fields of papers citing papers by Bjørnar Gilje

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bjørnar Gilje. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bjørnar Gilje. The network helps show where Bjørnar Gilje may publish in the future.

Co-authorship network of co-authors of Bjørnar Gilje

This figure shows the co-authorship network connecting the top 25 collaborators of Bjørnar Gilje. A scholar is included among the top collaborators of Bjørnar Gilje based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bjørnar Gilje. Bjørnar Gilje is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gilje, Bjørnar, Andrea Gombos, Ragnhild Sørum Falk, et al.. (2024). Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial. Journal for ImmunoTherapy of Cancer. 12(1). e007990–e007990. 8 indexed citations

Chauhan, Sudhir Kumar, Bjørnar Gilje, Sunil Xavier Raj, et al.. (2024). Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammation. npj Breast Cancer. 10(1). 30–30. 7 indexed citations

Borgen, Elin, Cecilie Bendigtsen Schirmer, Bjørnar Gilje, et al.. (2024). Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials. Molecular Oncology. 19(7). 2092–2108. 9 indexed citations

Helland, Åslaug, Geir Olav Hjortland, Line Bjørge, et al.. (2023). 1235P Enrichment of rare cancers in pragmatic precision cancer medicine trial: Experience from IMPRESS-Norway. Annals of Oncology. 34. S721–S722.

Mahesparan, Rupavathana, et al.. (2023). Impact of extent of resection on outcome from glioblastoma using the RANO resect group classification system: a retrospective, population-based cohort study. Neuro-Oncology Advances. 5(1). vdad126–vdad126. 12 indexed citations

Lapin, Morten, Kjersti Tjensvoll, Satu Oltedal, et al.. (2023). Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer. Clinical Cancer Research. 29(7). 1267–1278. 20 indexed citations

Lapin, Morten, et al.. (2023). Extracellular vesicles as a potential source of tumor-derived DNA in advanced pancreatic cancer. PLoS ONE. 18(9). e0291623–e0291623. 6 indexed citations

Gilje, Bjørnar, Andrea Gombos, Elin Borgen, et al.. (2022). 215MO ICON – a randomized phase IIb study evaluating chemotherapy combined with ipilimumab and nivolumab in metastatic hormone receptor-positive breast cancer. Annals of Oncology. 33. S636–S636. 3 indexed citations

Dalen, Ingvild, et al.. (2020). Measuring next of kin satisfaction with hospital cancer care: Using a mixed‐method approach as basis for improving quality and safety. Journal of Advanced Nursing. 76(5). 1232–1246. 9 indexed citations

10.

Lapin, Morten, Satu Oltedal, Kjersti Tjensvoll, et al.. (2018). Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer. Journal of Translational Medicine. 16(1). 300–300. 93 indexed citations

11.

Lapin, Morten, Kjersti Tjensvoll, Satu Oltedal, et al.. (2017). Single-cell mRNA profiling reveals transcriptional heterogeneity among pancreatic circulating tumour cells. BMC Cancer. 17(1). 390–390. 32 indexed citations

12.

Lapin, Morten, Kjersti Tjensvoll, Satu Oltedal, et al.. (2016). MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment. Scientific Reports. 6(1). 28929–28929. 34 indexed citations

13.

Tjensvoll, Kjersti, Morten Lapin, Satu Oltedal, et al.. (2015). Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer. Molecular Oncology. 10(4). 635–643. 118 indexed citations

14.

Tjensvoll, Kjersti, Morten Lapin, Satu Oltedal, et al.. (2015). Abstract 5241: Clinical relevance of circulating tumor DNA in plasma from pancreatic cancer patients. Cancer Research. 75(15_Supplement). 5241–5241. 1 indexed citations

15.

Tjensvoll, Kjersti, James M. Reuben, Satu Oltedal, et al.. (2012). miRNA expression profiling for identification of potential breast cancer biomarkers. Biomarkers. 17(5). 463–470. 8 indexed citations

16.

Nordgård, Oddmund, Satu Oltedal, Emiel A. M. Janssen, et al.. (2012). Comparison of a PNA Clamp PCR and an ARMS/Scorpion PCR Assay for the Detection of K-ras Mutations. Diagnostic Molecular Pathology. 21(1). 9–13. 14 indexed citations

17.

Gilje, Bjørnar, Oddmund Nordgård, Kjersti Tjensvoll, et al.. (2011). Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients. Breast Cancer Research and Treatment. 128(1). 137–146. 3 indexed citations

18.

Oltedal, Satu, Hartwig Kørner, Bjørnar Gilje, et al.. (2011). Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy. International Journal of Colorectal Disease. 26(10). 1271–1277. 35 indexed citations

19.

Nordgård, Oddmund, Satu Oltedal, Hartwig Kørner, et al.. (2009). Quantitative RT-PCR Detection of Tumor Cells in Sentinel Lymph Nodes Isolated From Colon Cancer Patients with an Ex Vivo Approach. Annals of Surgery. 249(4). 602–607. 33 indexed citations

20.

Samali, Afshin, Bjørnar Gilje, Stein Ove Døskeland, Thomas G. Cotter, & Gunnar Houge. (1997). The ability to cleave 28S ribosomal RNA during apoptosis is a cell-type dependent trait unrelated to DNA fragmentation. Cell Death and Differentiation. 4(4). 289–293. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact